The role of matrix in HIV-1 envelope glycoprotein incorporation

Trends in Microbiology

Volumn 22, Issue 7, 2014, Pages 372-378

  Tedbury, Philip R ^a   Freed, Eric O ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Assembly; Envelope; HIV 1; Matrix; Packaging

Indexed keywords

GAG PROTEIN; GLYCOPROTEIN GP 41; RAB11 PROTEIN; VIRUS ENVELOPE PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; P17 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1; PROTEIN BINDING;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BINDING AFFINITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; REVIEW; VIRION; VIRUS ASSEMBLY; VIRUS MUTATION; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS VIRULENCE; METABOLISM; PHYSIOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV ANTIGENS; HIV-1; PROTEIN BINDING; VIRUS ASSEMBLY;

EID: 84903579573     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2014.04.012     Document Type: Review

References (53)

1. Arts E.J., Hazuda D.J. HIV-1 antiretroviral drug therapy. Cold Spring Harb. Perspect. Med. 2012, 2:a007161.
2. Freed E.O., Martin M.A. HIVs and their replication. Field's Virology 2013, 1502-1560. Lippincott, Williams, and Wilkins. 6th edn. D.M. Knipe, P.M. Howley (Eds.).
3. Sundquist W.I., Kräusslich H-G. HIV-1 assembly, budding, and maturation. Cold Spring Harb. Perspect. Med. 2012, 2:a006924.
4. Ono A., et al. Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:14889-14894.
5. Chukkapalli V., Ono A. Molecular determinants that regulate plasma membrane association of HIV-1 Gag. J. Mol. Biol. 2011, 410:512-524.
6. Saad J.S., et al. Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:11364-11369.
7. Tang C., et al. Entropic switch regulates myristate exposure in the HIV-1 matrix protein. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:517-522.
8. Checkley M.A., et al. HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation. J. Mol. Biol. 2011, 410:582-608.
9. Steckbeck J.D., et al. C-terminal tail of human immunodeficiency virus gp41: functionally rich and structurally enigmatic. J. Gen. Virol. 2013, 94:1-19.
10. Santos da Silva E., et al. The frantic play of the concealed HIV envelope cytoplasmic tail. Retrovirology 2013, 10:54.
11. Viard M., et al. Photoinduced reactivity of the HIV-1 envelope glycoprotein with a membrane-embedded probe reveals insertion of portions of the HIV-1 Gp41 cytoplasmic tail into the viral membrane. Biochemistry 2008, 47:1977-1983.
12. Postler T.S., Desrosiers R.C. The tale of the long tail: the cytoplasmic domain of HIV-1 gp41. J. Virol. 2013, 87:2-15.
13. Johnson M.C. Mechanisms for Env glycoprotein acquisition by retroviruses. AIDS Res. Hum. Retroviruses 2011, 27:239-247.
14. Nguyen D.H., Hildreth J.E. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J. Virol. 2000, 74:3264-3272.
15. Ono A., Freed E.O. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:13925-13930.
16. Yang P., et al. The cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein gp41 harbors lipid raft association determinants. J. Virol. 2010, 84:59-75.
17. Bhattacharya J., et al. Human immunodeficiency virus type 1 envelope glycoproteins that lack cytoplasmic domain cysteines: impact on association with membrane lipid rafts and incorporation onto budding virus particles. J. Virol. 2004, 78:5500-5506.
18. Rousso I., et al. Palmitoylation of the HIV-1 envelope glycoprotein is critical for viral infectivity. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:13523-13525.
19. Vincent M.J., et al. Intracellular interaction of simian immunodeficiency virus Gag and Env proteins. J. Virol. 1999, 73:8138-8144.
20. Cosson P. Direct interaction between the envelope and matrix proteins of HIV-1. EMBO J. 1996, 15:5783-5788.
21. Manrique J.M., et al. In vitro binding of simian immunodeficiency virus matrix protein to the cytoplasmic domain of the envelope glycoprotein. Virology 2008, 374:273-279.
22. Freed E.O., et al. Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. J. Virol. 1994, 68:5311-5320.
23. Ono A., et al. Characterization of human immunodeficiency virus type 1 matrix revertants: effects on virus assembly, Gag processing, and Env incorporation into virions. J. Virol. 1997, 71:4409-4418.
24. Tedbury P.R., et al. Global rescue of defects in HIV-1 envelope glycoprotein incorporation: implications for matrix structure. PLoS Pathog. 2013, 9:e1003739.
25. Brandano L., Stevenson M. A highly conserved residue in the C-terminal helix of HIV-1 matrix is required for envelope incorporation into virus particles. J. Virol. 2012, 86:2347-2359.
26. Murakami T., Freed E.O. Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and α-helix 2 of the gp41 cytoplasmic tail. J. Virol. 2000, 74:3548-3554.
27. Freed E.O., Martin M.A. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J. Virol. 1995, 69:1984-1989.
28. Mammano F., et al. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains. J. Virol. 1995, 69:3824-3830.
29. Murakami T., Freed E.O. The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:343-348.
30. Akari H., et al. Cell-dependent requirement of human immunodeficiency virus type 1 gp41 cytoplasmic tail for Env incorporation into virions. J. Virol. 2000, 74:4891-4893.
31. Qi M., et al. Rab11-FIP1C and Rab14 direct plasma membrane sorting and particle incorporation of the HIV-1 envelope glycoprotein complex. PLoS Pathog. 2013, 9:e1003278.
32. Roy N.H., et al. Clustering and mobility of HIV-1 Env at viral assembly sites predict its propensity to induce cell-cell fusion. J. Virol. 2013, 87:7516-7525.
33. Muranyi W., et al. Super-resolution microscopy reveals specific recruitment of HIV-1 envelope proteins to viral assembly sites dependent on the envelope C-terminal tail. PLoS Pathog. 2013, 9:e1003198.
34. Fan G-H., et al. Rab11-family interacting protein 2 and myosin Vb are required for CXCR2 recycling and receptor-mediated chemotaxis. Mol. Biol. Cell 2004, 15:2456-2469.
35. Nedvetsky P.I., et al. A role of myosin Vb and Rab11-FIP2 in the aquaporin-2 shuttle. Traffic 2007, 8:110-123.
36. Jorgenson R.L., et al. Foreign glycoproteins can be actively recruited to virus assembly sites during pseudotyping. J. Virol. 2009, 83:4060-4067.
37. Zhu P., et al. Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:15812-15817.
38. Freed E.O., Martin M.A. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J. Virol. 1996, 70:341-351.
39. Hill C.P., et al. Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:3099-3104.
40. Alfadhli A., et al. HIV-1 matrix organizes as a hexamer of trimers on membranes containing phosphatidylinositol-(4,5)-bisphosphate. Virology 2009, 387:466-472.
41. Postler T.S., Desrosiers R.C. The cytoplasmic domain of the HIV-1 glycoprotein gp41 induces NF-κB activation through TGF-β-activated kinase 1. Cell Host Microbe 2012, 11:181-193.
42. Alfadhli A., et al. Human immunodeficiency virus type 1 matrix protein assembles on membranes as a hexamer. J. Virol. 2007, 81:1472-1478.
43. Wright E.R., et al. Electron cryotomography of immature HIV-1 virions reveals the structure of the CA and SP1 Gag shells. EMBO J. 2007, 26:2218-2226.
44. Huseby D., et al. Assembly of human immunodeficiency virus precursor gag proteins. J. Biol. Chem. 2005, 280:17664-17670.
45. Briggs J.A.G., Kräusslich H-G. The molecular architecture of HIV. J. Mol. Biol. 2011, 410:491-500.
46. Schnierle B.S., et al. Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:8640-8645.
47. Wilson C., et al. Formation of infectious hybrid virions with gibbon ape leukemia virus and human T-cell leukemia virus retroviral envelope glycoproteins and the gag and pol proteins of Moloney murine leukemia virus. J. Virol. 1989, 63:2374-2378.
48. Höhne M., et al. Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles. Virology 1999, 261:70-78.
49. Gregory D.A., et al. Multiple Gag domains contribute to selective MLV Env recruitment to MLV virions. J. Virol. 2012, 87:1518-1527.
50. Merk A., Subramaniam S. HIV-1 envelope glycoprotein structure. Curr. Opin. Struct. Biol. 2013, 23:268-276.
51. Rao Z., et al. Crystal structure of SIV matrix antigen and implications for virus assembly. Nature 1995, 378:743-747.
52. Morikawa Y., et al. Detection of a trimeric human immunodeficiency virus type 1 Gag intermediate is dependent on sequences in the matrix protein, p17. J. Virol. 1998, 72:7659-7663.
53. Reil H., et al. Efficient HIV-1 replication can occur in the absence of the viral matrix protein. EMBO J. 1998, 17:2699-2708.